Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.

Published

Journal Article

In an open-label study, 12 patients with refractory MG or who were taking only corticosteroids and required additional immunosuppression received mycophenolate mofetil 1 g twice daily for 6 months. A reduction of three points in a quantified MG score and two points in a manual muscle test or a reduction of 50% in corticosteroid dose defined efficacy. Eight patients improved, beginning after 2 weeks to 2 months. No major side effects were observed.

Full Text

Duke Authors

Cited Authors

  • Ciafaloni, E; Massey, JM; Tucker-Lipscomb, B; Sanders, DB

Published Date

  • January 9, 2001

Published In

Volume / Issue

  • 56 / 1

Start / End Page

  • 97 - 99

PubMed ID

  • 11148243

Pubmed Central ID

  • 11148243

International Standard Serial Number (ISSN)

  • 0028-3878

Digital Object Identifier (DOI)

  • 10.1212/wnl.56.1.97

Language

  • eng

Conference Location

  • United States